Euroopa Liit -
eesti -
EMA (European Medicines Agency)
nulojix
bristol-myers squibb pharma eeig - belatatsept - graft rejection; kidney transplantation - immunosupressandid - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
Eesti -
eesti -
Ravimiamet
atacand plus tablett
cheplapharm arzneimittel gmbh - kandesartaan+hüdroklorotiasiid - tablett - 32mg+12,5mg 300tk; 32mg+12,5mg 7tk
Eesti -
eesti -
Ravimiamet
atacand plus tablett
cheplapharm arzneimittel gmbh - kandesartaan+hüdroklorotiasiid - tablett - 16mg+12,5mg 30tk; 16mg+12,5mg 90tk; 16mg+12,5mg 300tk; 16mg+12,5mg 14tk; 16mg+12,5mg 98tk
Eesti -
eesti -
Ravimiamet
atacand plus tablett
cheplapharm arzneimittel gmbh - kandesartaan+hüdroklorotiasiid - tablett - 32mg+25mg 300tk; 32mg+25mg 30tk; 32mg+25mg 98tk; 32mg+25mg 28tk; 32mg+25mg 15tk; 32mg+25mg 7tk; 32mg+25mg 56tk
Eesti -
eesti -
Ravimiamet
atacand tablett
cheplapharm arzneimittel gmbh - kandesartaan - tablett - 16mg 100tk; 16mg 15tk; 16mg 90tk; 16mg 14tk; 16mg 300tk; 16mg 30tk; 16mg 28tk; 16mg 56tk; 16mg 250tk
Eesti -
eesti -
Ravimiamet
atacand tablett
cheplapharm arzneimittel gmbh - kandesartaan - tablett - 32mg 250tk; 32mg 7tk; 32mg 28tk; 32mg 98tk; 32mg 30tk; 32mg 100tk